WASHINGTON -- Medicare recipients will get a premium reduction — but not until next year — reflecting an overestimate in costs of covering an expensive and controversial new Alzheimer's drug.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
